4101
|
Mitsumori M, Adachi T, Takayanagi K, Mito T, Ohuchi H, Kimura S, Kokubo M, Higuchi T, Noji S. Film tomography as a tool for three-dimensional image construction and gene expression studies. Dev Growth Differ 2007; 49:583-9. [PMID: 17587324 DOI: 10.1111/j.1440-169x.2007.00948.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In order to observe three-dimensional (3D) expression patterns of genes in whole animals, whole organs, or whole tissues, in situ hybridization (ISH) of many sections must be carried out and then used to construct a 3D image. For this purpose, we have developed an automatic microtome to prepare tissue sections with an adhesive film. We used commercially available film suitable for sectioning and ISH. We constructed a microtome and, after adherence of the film to a paraffin-embedded tissue block, cut the block with a blade to prepare sections on film. Then, the sections-on-film were automatically set in a plastic frame that was the same size as a conventional glass slide. With this automatic microtome, tissue sections can be made for ISH or immunohistochemistry in addition to conventional hematoxylin and eosin staining without specific training. We demonstrate that we can construct 3D images of gene expression patterns obtained by ISH on sections prepared with this automatic microtome. We have designated this method as 'Film Tomography (FITO)'.
Collapse
|
4102
|
Polleux F, Ince-Dunn G, Ghosh A. Transcriptional regulation of vertebrate axon guidance and synapse formation. Nat Rev Neurosci 2007; 8:331-40. [PMID: 17453014 DOI: 10.1038/nrn2118] [Citation(s) in RCA: 131] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
The establishment of functional neural connections requires the growth of axons to specific target areas and the formation of synapses with appropriate synaptic partners. Several molecules that regulate axon guidance and synapse formation have been identified in the past decade, but it is unclear how a relatively limited number of factors can specify a large number of connections. Recent evidence indicates that transcription factors make a crucial contribution to the specification of connections in the nervous system by coordinating the response of neurons to guidance molecules and neurotransmitters.
Collapse
Affiliation(s)
- Franck Polleux
- Neuroscience Center, Department of Pharmacology, Neurodevelopmental Diseases Research Center, University of North Carolina, Chapel Hill, North Carolina 27599-7250, USA
| | | | | |
Collapse
|
4103
|
Schmidt WM, Kraus C, Höger H, Hochmeister S, Oberndorfer F, Branka M, Bingemann S, Lassmann H, Müller M, Macedo-Souza LI, Vainzof M, Zatz M, Reis A, Bittner RE. Mutation in the Scyl1 gene encoding amino-terminal kinase-like protein causes a recessive form of spinocerebellar neurodegeneration. EMBO Rep 2007; 8:691-7. [PMID: 17571074 PMCID: PMC1905899 DOI: 10.1038/sj.embor.7401001] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2007] [Revised: 04/30/2007] [Accepted: 04/30/2007] [Indexed: 01/31/2023] Open
Abstract
Here, we show that the murine neurodegenerative disease mdf (autosomal recessive mouse mutant 'muscle deficient') is caused by a loss-of-function mutation in Scyl1, disrupting the expression of N-terminal kinase-like protein, an evolutionarily conserved putative component of the nucleocytoplasmic transport machinery. Scyl1 is prominently expressed in neurons, and enriched at central nervous system synapses and neuromuscular junctions. We show that the pathology of mdf comprises cerebellar atrophy, Purkinje cell loss and optic nerve atrophy, and therefore defines a new animal model for neurodegenerative diseases with cerebellar involvement in humans.
Collapse
Affiliation(s)
- Wolfgang M Schmidt
- Neuromuscular Research Department, Center of Anatomy & Cell Biology, Medical University of Vienna, Währinger Strasse 13, A-1090 Vienna, Austria
- Department of Clinical Pharmacology, Section of Cardiovascular Medicine, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria
| | - Cornelia Kraus
- Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Schwabachanlage 10, D-91054 Erlangen, Germany
| | - Harald Höger
- Division for Laboratory Animal Science and Genetics, Medical University of Vienna, Brauhausgasse 34, A-2325 Himberg, Austria
| | - Sonja Hochmeister
- Center for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria
| | - Felicitas Oberndorfer
- Neuromuscular Research Department, Center of Anatomy & Cell Biology, Medical University of Vienna, Währinger Strasse 13, A-1090 Vienna, Austria
| | - Manuela Branka
- Neuromuscular Research Department, Center of Anatomy & Cell Biology, Medical University of Vienna, Währinger Strasse 13, A-1090 Vienna, Austria
| | - Sonja Bingemann
- Neuromuscular Research Department, Center of Anatomy & Cell Biology, Medical University of Vienna, Währinger Strasse 13, A-1090 Vienna, Austria
| | - Hans Lassmann
- Center for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria
| | - Markus Müller
- Department of Clinical Pharmacology, Section of Cardiovascular Medicine, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria
| | - Lúcia Inês Macedo-Souza
- Department of Biology, Institute of Biological Sciences and Center for Study of Human Genome, University of São Paulo, Rua do Matão, 277 Cidade Universitária, São Paulo, Brazil
| | - Mariz Vainzof
- Department of Biology, Institute of Biological Sciences and Center for Study of Human Genome, University of São Paulo, Rua do Matão, 277 Cidade Universitária, São Paulo, Brazil
| | - Mayana Zatz
- Department of Biology, Institute of Biological Sciences and Center for Study of Human Genome, University of São Paulo, Rua do Matão, 277 Cidade Universitária, São Paulo, Brazil
| | - André Reis
- Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Schwabachanlage 10, D-91054 Erlangen, Germany
| | - Reginald E Bittner
- Neuromuscular Research Department, Center of Anatomy & Cell Biology, Medical University of Vienna, Währinger Strasse 13, A-1090 Vienna, Austria
- Tel: +43 664 80016 37514; Fax: +43 1 4277 61198; E-mail:
| |
Collapse
|
4104
|
da Rocha ST, Tevendale M, Knowles E, Takada S, Watkins M, Ferguson-Smith AC. Restricted co-expression of Dlk1 and the reciprocally imprinted non-coding RNA, Gtl2: implications for cis-acting control. Dev Biol 2007; 306:810-23. [PMID: 17449025 DOI: 10.1016/j.ydbio.2007.02.043] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2007] [Revised: 02/26/2007] [Accepted: 02/27/2007] [Indexed: 11/17/2022]
Abstract
Dlk1 and Gtl2 are reciprocally imprinted neighboring genes located within a 1 Mb imprinted domain on murine distal chromosome 12. The two genes are expressed and developmentally regulated during mammalian embryogenesis. Dlk1/Pref1 encodes a transmembrane protein with homology to members of the Notch/Delta developmental signaling pathway and Gtl2 generates alternatively spliced poly-adenylated transcripts lacking a conserved open reading frame. An intergenic differentially methylated region (IG-DMR) located 13 kb upstream of Gtl2 has been shown to regulate imprinting throughout the domain by an as yet unknown mechanism. In order to gain insights into regulation at this domain and to compare it with imprinting control at other loci, we compared the expression profile of Dlk1 with Gtl2 during mouse embryogenesis in normal conceptuses and in those with uniparental disomy for chromosome 12. The expression profile of these genes suggests a causative role for Dlk1 and Gtl2 in the pathologies found in uniparental disomy animals, characterized by defects in skeletal muscle maturation, bone formation, placenta size and organization and prenatal lethality. Here, we show restricted overlap in cellular expression of these two genes throughout development. Dlk1 is imprinted and expressed in cell types within the lung, liver and placenta where Gtl2 is not expressed. Gtl2 is highly expressed in the central nervous system (CNS), whereas Dlk1 is found localized to specific regions such as the hypothalamus. Co-expression is observed in most of the mesodermal-derived tissues, notably the skeletal muscle where both genes are strongly co-expressed. In this tissue, Dlk1 shows a relaxation of imprinting with some expression from the maternal allele. These findings indicate that the general mechanism of imprinting at the stages analyzed is not through the co-ordinate non-coding RNA or insulator mechanisms observed for other imprinted domains, and suggest that the two genes have independent tissue-specific functions.
Collapse
Affiliation(s)
- Simão T da Rocha
- Department of Physiology, Development and Neurosciences, University of Cambridge, Downing Street, Cambridge, UK
| | | | | | | | | | | |
Collapse
|
4105
|
Le Novère N. The long journey to a Systems Biology of neuronal function. BMC SYSTEMS BIOLOGY 2007; 1:28. [PMID: 17567903 PMCID: PMC1904462 DOI: 10.1186/1752-0509-1-28] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/13/2007] [Accepted: 06/13/2007] [Indexed: 11/10/2022]
Abstract
Computational neurobiology was born over half a century ago, and has since been consistently at the forefront of modelling in biology. The recent progress of computing power and distributed computing allows the building of models spanning several scales, from the synapse to the brain. Initially focused on electrical processes, the simulation of neuronal function now encompasses signalling pathways and ion diffusion. The flow of quantitative data generated by the "omics" approaches, alongside the progress of live imaging, allows the development of models that will also include gene regulatory networks, protein movements and cellular remodelling. A systems biology of brain functions and disorders can now be envisioned. As it did for the last half century, neuroscience can drive forward the field of systems biology.
Collapse
|
4106
|
Jaworski J. ARF6 in the nervous system. Eur J Cell Biol 2007; 86:513-24. [PMID: 17559968 DOI: 10.1016/j.ejcb.2007.04.007] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2007] [Revised: 04/11/2007] [Accepted: 04/18/2007] [Indexed: 01/19/2023] Open
Abstract
Actin cytoskeleton dynamics and membrane trafficking are tightly connected and are among the most important driving forces of neuronal development, basic synaptic transmission events, and synaptic plasticity. One group of proteins involved in coordination of these two processes is the family of ADP ribosylation factors (ARFs) regulating actin dynamics, lipid modification and membrane trafficking. ARF6 is the only member of the ARF family that can simultaneously regulate actin cytoskeleton changes and membrane exchange between plasma membrane and endocytic compartments. The presence of ARF6 and its guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) in the brain, as well as its capability to regulate several aspects of neuronal development and synaptic plasticity, has been recently demonstrated. The main purpose of this review is to present the current knowledge about how ARF6 can influence morphological processes crucial for proper formation of the neuronal circuits in the brain, including dendrite and axon differentiation, development of dendritic arbor complexity and dendritic spine formation. Potential effects of ARF6 on synaptic events resulting from its ability to control exo- and endocytosis will be also discussed.
Collapse
Affiliation(s)
- Jacek Jaworski
- Laboratory of Molecular and Cell Neurobiology, International Institute of Molecular and Cell Biology, Ks. Trojdena St. 4, PL-02-109, Warsaw, Poland.
| |
Collapse
|
4107
|
Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007; 54:713-20. [PMID: 17553421 PMCID: PMC2587162 DOI: 10.1016/j.neuron.2007.05.022] [Citation(s) in RCA: 341] [Impact Index Per Article: 18.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2007] [Revised: 05/15/2007] [Accepted: 05/20/2007] [Indexed: 11/28/2022]
Abstract
The apolipoprotein E (APOE) epsilon4 allele is the best established genetic risk factor for late-onset Alzheimer's disease (LOAD). We conducted genome-wide surveys of 502,627 single-nucleotide polymorphisms (SNPs) to characterize and confirm other LOAD susceptibility genes. In epsilon4 carriers from neuropathologically verified discovery, neuropathologically verified replication, and clinically characterized replication cohorts of 1411 cases and controls, LOAD was associated with six SNPs from the GRB-associated binding protein 2 (GAB2) gene and a common haplotype encompassing the entire GAB2 gene. SNP rs2373115 (p = 9 x 10(-11)) was associated with an odds ratio of 4.06 (confidence interval 2.81-14.69), which interacts with APOE epsilon4 to further modify risk. GAB2 was overexpressed in pathologically vulnerable neurons; the Gab2 protein was detected in neurons, tangle-bearing neurons, and dystrophic neuritis; and interference with GAB2 gene expression increased tau phosphorylation. Our findings suggest that GAB2 modifies LOAD risk in APOE epsilon4 carriers and influences Alzheimer's neuropathology.
Collapse
Affiliation(s)
- Eric M. Reiman
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Banner Alzheimer’s Institute, Phoenix, AZ 85006, USA
- Department of Psychiatry, University of Arizona, Tucson, AZ 85724, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Jennifer A. Webster
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Amanda J. Myers
- Department of Psychiatry and Behavioral Sciences, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
| | - John Hardy
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
- Reta Lila Weston Laboratories, Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N, 3BG, England
| | - Travis Dunckley
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Victoria L. Zismann
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Keta D. Joshipura
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - John V. Pearson
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Diane Hu-Lince
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Matthew J. Huentelman
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - David W. Craig
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Keith D. Coon
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Division of Thoracic Oncology Research, St. Joseph’s Hospital, Phoenix, AZ 85013, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Winnie S. Liang
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - RiLee H. Herbert
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Thomas Beach
- Sun Health Research Institute, Sun City, AZ 85351, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Kristen C. Rohrer
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
| | - Alice S. Zhao
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
| | - Doris Leung
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
| | - Leslie Bryden
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
| | - Lauren Marlowe
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
| | - Mona Kaleem
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA
| | | | - Andrew Grover
- Sun Health Research Institute, Sun City, AZ 85351, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | | | - Rivka Ravid
- Netherlands Institute for Neurosciences, Dutch Royal Academy of Arts and Sciences, Meibergdreef 47 AB Amsterdam, The Netherlands
| | - Joseph Rogers
- Sun Health Research Institute, Sun City, AZ 85351, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Michael L. Hutton
- Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
| | - Stacey Melquist
- Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
| | - Ron C. Petersen
- Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
| | - Gene E. Alexander
- Department of Psychology, Arizona State University, Tempe, AZ 85281, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Richard J. Caselli
- Department of Neurology, Mayo Clinic, Scottsdale, AZ 85259, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| | - Walter Kukull
- National Alzheimer’s Coordinating Center, Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA 98195, USA
| | - Andreas Papassotiropoulos
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Division of Molecular Psychology and Life Sciences Training Facility, Biozentrum, University of Basel, Switzerland
| | - Dietrich A. Stephan
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
- Banner Alzheimer’s Institute, Phoenix, AZ 85006, USA
- Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA
| |
Collapse
|
4108
|
Kato AS, Zhou W, Milstein AD, Knierman MD, Siuda ER, Dotzlaf JE, Yu H, Hale JE, Nisenbaum ES, Nicoll RA, Bredt DS. New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci 2007; 27:4969-77. [PMID: 17475805 PMCID: PMC6672084 DOI: 10.1523/jneurosci.5561-06.2007] [Citation(s) in RCA: 117] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
AMPA-type glutamate receptors (GluRs) mediate most excitatory signaling in the brain and are composed of GluR principal subunits and transmembrane AMPA receptor regulatory protein (TARP) auxiliary subunits. Previous studies identified four mammalian TARPs, gamma-2 (or stargazin), gamma-3, gamma-4, and gamma-8, that control AMPA receptor trafficking, gating, and pharmacology. Here, we explore roles for the homologous gamma-5 and gamma-7 proteins, which were previously suggested not to serve as TARPs. Western blotting reveals high levels of gamma-5 and gamma-7 in the cerebellum, where gamma-7 is enriched in Purkinje neurons in the molecular layer and glomerular synapses in the granule cell layer. Immunoprecipitation proteomics shows that cerebellar gamma-7 avidly and selectively binds to AMPA receptor GluR subunits and also binds to the AMPA receptor clustering protein, postsynaptic density-95 (PSD-95). Furthermore, gamma-7 occurs together with PSD-95 and AMPA receptor subunits in purified postsynaptic densities. In heterologous cells, gamma-7 but not gamma-5 greatly enhances AMPA receptor glutamate-evoked currents and modulates channel gating. In granule cells from stargazer mice, transfection of gamma-7 but not gamma-5 increases AMPA receptor-mediated currents. Compared with stargazin, gamma-7 differentially modulates AMPA receptor glutamate affinity and kainate efficacy. These studies define gamma-7 as a new member of the TARP family that can differentially influence AMPA receptors in cerebellar neurons.
Collapse
Affiliation(s)
| | - Wei Zhou
- Departments of Physiology, and Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94143
| | - Aaron D. Milstein
- Departments of Physiology, and Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94143
| | | | | | | | | | | | | | - Roger A. Nicoll
- Departments of Physiology, and Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94143
| | - David S. Bredt
- Neuroscience Discovery and
- Integrated Biology, Lilly Research Laboratories
| |
Collapse
|
4109
|
Hofstetter AO, Saha S, Siljehav V, Jakobsson PJ, Herlenius E. The induced prostaglandin E2 pathway is a key regulator of the respiratory response to infection and hypoxia in neonates. Proc Natl Acad Sci U S A 2007; 104:9894-9. [PMID: 17535900 PMCID: PMC1877988 DOI: 10.1073/pnas.0611468104] [Citation(s) in RCA: 94] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2007] [Indexed: 11/18/2022] Open
Abstract
Infection during the neonatal period commonly induces apnea episodes, and the proinflammatory cytokine IL-1beta may serve as a critical mediator between these events. To determine the mechanism by which IL-1beta depresses respiration, we examined a prostaglandin E(2) (PGE(2))-dependent pathway in newborn mice and human neonates. IL-1beta and transient anoxia rapidly induced brainstem-specific microsomal prostaglandin E synthase-1 (mPGES-1) activity in neonatal mice. Furthermore, IL-1beta reduced respiratory frequency during hyperoxia and depressed hypoxic gasping and autoresuscitation in mPGES-1 wild-type mice, but not in mPGES-1 knockout mice. In wild-type mice, PGE(2) induced apnea and irregular breathing patterns in vivo and inhibited brainstem respiratory rhythm generation in vitro. Mice lacking the EP3 receptor (EP3R) for PGE(2) exhibited fewer apneas and sustained brainstem respiratory activity, demonstrating that PGE(2) exerts its respiratory effects via EP3R. In human neonates, the infectious marker C-reactive protein was correlated with elevated PGE(2) in the cerebrospinal fluid, and elevated central PGE(2) was associated with an increased apnea frequency. We conclude that IL-1beta adversely affects breathing and its control by mPGES-1 activation and PGE(2) binding to brainstem EP3 receptors, resulting in increased apnea frequency and hypoxia-induced mortality.
Collapse
Affiliation(s)
- Annika O. Hofstetter
- *Department of Woman and Child Health, Karolinska Institutet, 171 76 Stockholm, Sweden
| | - Sipra Saha
- *Department of Woman and Child Health, Karolinska Institutet, 171 76 Stockholm, Sweden
- Centre for Structural Biochemistry, Karolinska Institutet, Novum, 141 57 Huddinge, Sweden; and
| | - Veronica Siljehav
- *Department of Woman and Child Health, Karolinska Institutet, 171 76 Stockholm, Sweden
| | - Per-Johan Jakobsson
- Department of Medicine, Karolinska Proteonic Center, Karolinska University Hospital, S-171 76, Stockholm, Sweden
| | - Eric Herlenius
- *Department of Woman and Child Health, Karolinska Institutet, 171 76 Stockholm, Sweden
| |
Collapse
|
4110
|
Gao J, Maison SF, Wu X, Hirose K, Jones SM, Bayazitov I, Tian Y, Mittleman G, Matthews DB, Zakharenko SS, Liberman MC, Zuo J. Orphan glutamate receptor delta1 subunit required for high-frequency hearing. Mol Cell Biol 2007; 27:4500-12. [PMID: 17438141 PMCID: PMC1900048 DOI: 10.1128/mcb.02051-06] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2006] [Revised: 11/29/2006] [Accepted: 04/06/2007] [Indexed: 11/20/2022] Open
Abstract
The function of the orphan glutamate receptor delta subunits (GluRdelta1 and GluRdelta2) remains unclear. GluRdelta2 is expressed exclusively in the Purkinje cells of the cerebellum, and GluRdelta1 is prominently expressed in inner ear hair cells and neurons of the hippocampus. We found that mice lacking the GluRdelta1 protein displayed significant cochlear threshold shifts for frequencies of >16 kHz. These deficits correlated with a substantial loss of type IV spiral ligament fibrocytes and a significant reduction of endolymphatic potential in high-frequency cochlear regions. Vulnerability to acoustic injury was significantly enhanced; however, the efferent innervation of hair cells and the classic efferent inhibition of outer hair cells were unaffected. Hippocampal and vestibular morphology and function were normal. Our findings show that the orphan GluRdelta1 plays an essential role in high-frequency hearing and ionic homeostasis in the basal cochlea, and the locus encoding GluRdelta1 represents a candidate gene for congenital or acquired high-frequency hearing loss in humans.
Collapse
Affiliation(s)
- Jiangang Gao
- Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN 38105, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4111
|
Lerchner W, Xiao C, Nashmi R, Slimko EM, van Trigt L, Lester HA, Anderson DJ. Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl- channel. Neuron 2007; 54:35-49. [PMID: 17408576 DOI: 10.1016/j.neuron.2007.02.030] [Citation(s) in RCA: 138] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2006] [Revised: 02/09/2007] [Accepted: 02/22/2007] [Indexed: 02/03/2023]
Abstract
Several genetic strategies for inhibiting neuronal function in mice have been described, but no system that directly suppresses membrane excitability and is triggered by a systemically administered drug, has been validated in awake behaving animals. We expressed unilaterally in mouse striatum a modified heteromeric ivermectin (IVM)-gated chloride channel from C. elegans (GluClalphabeta), systemically administered IVM, and then assessed amphetamine-induced rotational behavior. Rotation was observed as early as 4 hr after a single intraperitoneal IVM injection (10 mg/kg), reached maximal levels by 12 hr, and was almost fully reversed by 4 days. Multiple cycles of silencing and recovery could be performed in a single animal. In striatal slice preparations from GluClalphabeta-expressing animals, IVM rapidly suppressed spiking. The two-subunit GluCl/IVM system permits "intersectional" strategies designed to increase the cellular specificity of silencing in transgenic animals.
Collapse
Affiliation(s)
- Walter Lerchner
- Division of Biology 216-76, California Institute of Technology, Pasadena, CA 91125, USA
| | | | | | | | | | | | | |
Collapse
|
4112
|
Mulder J, Wernérus H, Shi TJ, Pontén F, Hober S, Uhlén M, Hökfelt T. Systematically generated antibodies against human gene products: High throughput screening on sections from the rat nervous system. Neuroscience 2007; 146:1689-703. [PMID: 17478047 DOI: 10.1016/j.neuroscience.2007.02.054] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2007] [Revised: 02/14/2007] [Accepted: 02/20/2007] [Indexed: 10/23/2022]
Abstract
Completion of the Human Genome Project and recent developments in proteomics make it possible to systematically generate affinity reagents to a large portion of the proteome. Recently an antibody-based human protein atlas covering many organs including four areas of the brain has been released (www.proteinatlas.org). Due to the heterogeneity, size, and availability of tissue a more thorough analysis of the human brain is associated with considerable difficulties. Here we applied 120 antibodies raised against 112 human gene products to the smaller rat brain, a rodent animal model, where a single section represents a 'superarray' including many brain areas, and consequently allowing analysis of a huge number of cell types and their neurochemicals. Immunoreactive structures were seen in the investigated brain tissue after incubation with 56 antibodies (46.6%), of which 25 (20.8%) showed a clearly discrete staining pattern that was limited to certain areas, or subsets of brain cells. Bioinformatics, pre-adsorption tests and Western blot analysis were applied to identify non-specific antibodies. Eleven antibodies, including such raised against four 'ambiguous' proteins, passed all validation criteria, and the expression pattern and subcellular distribution of these proteins were studied in detail. To further explore the potential of the systematically generated antibodies, all 11 antibodies that passed validation were used to analyze the spinal cord and lumbar dorsal root ganglia after unilateral transection of the sciatic nerve. Discrete staining patterns were observed for four of the proteins, and injury-induced regulation was found for one of them. In conclusion, the study presented here suggests that a significant portion (10%) of the antibodies generated to a human protein can be used to analyze orthologues present in the rodent brain and to produce a protein-based atlas of the rodent brain. It is hoped that this type of antibody-based, high throughput screening of brain tissue from various rodent disease models will provide new information on the brain chemical neuroanatomy and insights in processes underlying neurological pathologies.
Collapse
Affiliation(s)
- J Mulder
- Department of Neuroscience, Karolinska Institutet, Retzius v. 8, S171 77 Stockholm, Sweden.
| | | | | | | | | | | | | |
Collapse
|
4113
|
Dai Y, Wolfgang MJ, Cha SH, Lane MD. Localization and effect of ectopic expression of CPT1c in CNS feeding centers. Biochem Biophys Res Commun 2007; 359:469-74. [PMID: 17559810 DOI: 10.1016/j.bbrc.2007.05.161] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2007] [Accepted: 05/18/2007] [Indexed: 11/29/2022]
Abstract
Hypothalamic neurons monitor peripheral energy status and produce signals to adjust food intake and energy expenditure to maintain homeostasis. However, the molecular mechanisms by which these signals are generated remain unclear. Fluctuations in the level of hypothalamic malonyl-CoA are known to serve as an intermediary in regulating energy homeostasis and it has been proposed that the brain-specific carnitine palmitoyltransferase-1c (CPT1c) serves as a target of malonyl-CoA in the central nervous system (CNS). Here, we report that CPT1c is widely expressed in neurons throughout the CNS including the hypothalamus, hippocampus, cortex, and amygdala. CPT1c is enriched in neural feeding centers of the hypothalamus with mitochondrial localization as an outer integral membrane protein. Ectopic over-expression of CPT1c by stereotactic hypothalamic injection of a CPT1c adenoviral vector is sufficient to protect mice from body weight gain when fed a high-fat diet. These findings show that CPT1c is appropriately localized in regions and cell types to regulate energy homeostasis and that its over-expression in the hypothalamus is sufficient to protect mice from adverse weight gain caused by high-fat intake.
Collapse
Affiliation(s)
- Yun Dai
- Department of Biological Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolfe St. 512 WBSB, Baltimore, MD 21205, USA
| | | | | | | |
Collapse
|
4114
|
Castelli L, Biella G, Toselli M, Magistretti J. Resurgent Na+ current in pyramidal neurones of rat perirhinal cortex: axonal location of channels and contribution to depolarizing drive during repetitive firing. J Physiol 2007; 582:1179-93. [PMID: 17525112 PMCID: PMC2075234 DOI: 10.1113/jphysiol.2007.135350] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
The perirhinal cortex (PRC) is a supra-modal cortical area that collects and integrates information originating from uni- and multi-modal neocortical regions and directed to the hippocampus. The mechanisms that underlie the specific excitable properties of the different PRC neuronal types are still largely unknown, and their elucidation may be important in understanding the integrative functions of PRC. In this study we investigated the expression and properties of resurgent Na(+) current (I(NaR)) in pyramidal neurones of rat PRC area 35 (layer II). Patch-clamp experiments in acute PRC slices were first carried out. A measurable I(NaR) was expressed by a large majority of neurones (31 out of 35 cells). I(NaR) appeared as an inward, slowly decaying current elicited upon step repolarization after depolarizations sufficient to induce nearly complete inactivation of the transient Na(+) current (I(NaT)). I(NaR) had a peak amplitude of approximately 2.5% that of I(NaT), and showed the typical biophysical properties also observed in other neuronal types (i.e. cerebellar Purkinje and granule cells), including a bell-shaped current-voltage relationship with a peak at approximately -40 mV, and a characteristic acceleration of activation and decay speed at potentials negative to -45 mV. Current-clamp experiments were then carried out in which repetitive action-potential discharge at various frequencies was induced with depolarizing current injection. The voltage signals thus obtained were then used as command waveforms for voltage-clamp recordings. These experiments showed that a Na(+) current identifiable as I(NaR) activates in the early interspike phase even at relatively high firing frequencies (20 Hz), thereby contributing to the depolarizing drive and possibly enhancing repetitive discharge. In acutely dissociated area 35 layer II neurones, as well as in nucleated patches from the same neurones, I(NaR) was never observed, despite the presence of typical I(NaT)s. Since in both preparations neuronal processes are lost, we carried out experiments of focal tetrodotoxin (TTX) application in slices to verify whether the channels responsible for I(NaR) are located in compartment(s) different from the soma. We found that TTX preferentially inhibited I(NaR) when applied close to the site of axon emergence from soma, whereas application to the apical pole of the soma had a significantly smaller effect on I(NaR). Our results indicate that in area 35 pyramidal cells I(NaR) is largely generated in the axon initial segment, where it may participate in setting the coding properties of these neurones.
Collapse
Affiliation(s)
- Loretta Castelli
- Dipartimento di Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari, Sezione di Fisiologia Generale e Biofisica Cellulare, Università degli Studi di Pavia, Via Forlanini 6, 27100 Pavia, Italy
| | | | | | | |
Collapse
|
4115
|
Grant SGN. Toward a molecular catalogue of synapses. ACTA ACUST UNITED AC 2007; 55:445-9. [PMID: 17572504 DOI: 10.1016/j.brainresrev.2007.05.003] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2006] [Revised: 04/30/2007] [Accepted: 05/07/2007] [Indexed: 11/30/2022]
Abstract
1906 was a landmark year in the history of the study of the nervous system, most notably for the first 'neuroscience' Nobel prize given to the anatomists Ramon Y Cajal and Camillo Golgi. 1906 is less well known for another event, also of great significance for neuroscience, namely the publication of Charles Sherrington's book 'The Integrative Action of the Nervous system'. It was Cajal and Golgi who debated the anatomical evidence for the synapse and it was Sherrington who laid its foundation in electrophysiological function. In tribute to these pioneers in synaptic biology, this article will address the issue of synapse diversity from the molecular point of view. In particular I will reflect upon efforts to obtain a complete molecular characterisation of the synapse and the unexpectedly high degree of molecular complexity found within it. A case will be made for developing approaches that can be used to generate a general catalogue of synapse types based on molecular markers, which should have wide application.
Collapse
Affiliation(s)
- Seth G N Grant
- Genes to Cognition Programme, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, Cambridgeshire, UK.
| |
Collapse
|
4116
|
Andrade N, Komnenovic V, Blake SM, Jossin Y, Howell B, Goffinet A, Schneider WJ, Nimpf J. ApoER2/VLDL receptor and Dab1 in the rostral migratory stream function in postnatal neuronal migration independently of Reelin. Proc Natl Acad Sci U S A 2007; 104:8508-13. [PMID: 17494763 PMCID: PMC1895980 DOI: 10.1073/pnas.0611391104] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Postnatal migration of interneuron precursors from the subventricular zone to the olfactory bulb occurs in chains that form the substrate for the rostral migratory stream. Reelin is suggested to induce detachment of neuroblasts from the chains when they arrive at the olfactory bulb. Here we show that ApoER2 and possibly very-low-density lipoprotein receptor (VLDLR) and their intracellular adapter protein Dab1 are involved in chain formation most likely independent of Reelin. F-spondin, which is present in the stream, may act as ligand for ApoER2 and VLDLR. In mice lacking either both receptors or Dab1 chain formation is severely compromised, and as a consequence the rostral migratory stream is virtually absent and neuroblasts accumulate in the subventricular zone. The mutant animals exhibit severe neuroanatomical defects in the subventricular zone and in the olfactory bulb. These data demonstrate a cell-autonomous function of ApoER2, and most likely VLDLR and Dab1, in postnatal migration of neuroblasts in the forebrain, which is suggested to depend on ligands other than Reelin.
Collapse
Affiliation(s)
- Nuno Andrade
- *Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, A-1030 Vienna, Austria
| | - Vukoslav Komnenovic
- Institute of Molecular Biotechnology, Austrian Academy of Sciences, 1030 Vienna, Austria
| | - Sophia M. Blake
- *Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, A-1030 Vienna, Austria
| | - Yves Jossin
- Developmental Neurobiology Unit, University of Leuven Medical School, 3000 Leuven, Belgium; and
| | - Brian Howell
- Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892
| | - Andre Goffinet
- Developmental Neurobiology Unit, University of Leuven Medical School, 3000 Leuven, Belgium; and
| | - Wolfgang J. Schneider
- *Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, A-1030 Vienna, Austria
| | - Johannes Nimpf
- *Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, A-1030 Vienna, Austria
- To whom correspondence should be addressed. E-mail:
| |
Collapse
|
4117
|
|
4118
|
Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30:194-202. [PMID: 17408759 DOI: 10.1016/j.tins.2007.03.006] [Citation(s) in RCA: 1197] [Impact Index Per Article: 66.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2007] [Revised: 02/23/2007] [Accepted: 03/19/2007] [Indexed: 10/23/2022]
Abstract
The basic organization of the catecholamine-containing neuronal systems and their axonal projections in the brain was initially worked out using classical histofluorescence techniques during the 1960s and 1970s. The introduction of more versatile immunohistochemical methods, along with a range of highly sensitive tract-tracing techniques, has provided a progressively more detailed picture, making the dopamine system one of the best known, and most completely mapped, neurotransmitter systems in the brain. The purpose of the present review is to summarize our current knowledge of the diversity and neurochemical features of the nine dopamine-containing neuronal cell groups in the mammalian brain, their distinctive cellular properties, and their ability to regulate their dopaminergic transmitter machinery in response to altered functional demands and aging.
Collapse
Affiliation(s)
- Anders Björklund
- Neurobiology Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, Lund SE-22184, Sweden.
| | | |
Collapse
|
4119
|
Zalfa F, Eleuteri B, Dickson KS, Mercaldo V, De Rubeis S, di Penta A, Tabolacci E, Chiurazzi P, Neri G, Grant SG, Bagni C. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 2007; 10:578-87. [PMID: 17417632 PMCID: PMC2804293 DOI: 10.1038/nn1893] [Citation(s) in RCA: 290] [Impact Index Per Article: 16.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2006] [Accepted: 03/14/2007] [Indexed: 11/09/2022]
Abstract
Fragile X syndrome (FXS) results from the loss of the fragile X mental retardation protein (FMRP), an RNA-binding protein that regulates a variety of cytoplasmic mRNAs. FMRP regulates mRNA translation and may be important in mRNA localization to dendrites. We report a third cytoplasmic regulatory function for FMRP: control of mRNA stability. In mice, we found that FMRP binds, in vivo, the mRNA encoding PSD-95, a key molecule that regulates neuronal synaptic signaling and learning. This interaction occurs through the 3' untranslated region of the PSD-95 (also known as Dlg4) mRNA, increasing message stability. Moreover, stabilization is further increased by mGluR activation. Although we also found that the PSD-95 mRNA is synaptically localized in vivo, localization occurs independently of FMRP. Through our functional analysis of this FMRP target we provide evidence that dysregulation of mRNA stability may contribute to the cognitive impairments in individuals with FXS.
Collapse
Affiliation(s)
- Francesca Zalfa
- Dipartimento di Biologia, Università “Tor Vergata”, Via della Ricerca Scientifica 1. 00133 Rome, Italy
- Istituto di Neuroscienze Sperimentali, Fondazione Santa Lucia, Via del Fosso di Fiorano 63, 00143 Rome, Italy
| | - Boris Eleuteri
- Dipartimento di Biologia, Università “Tor Vergata”, Via della Ricerca Scientifica 1. 00133 Rome, Italy
- Istituto di Neuroscienze Sperimentali, Fondazione Santa Lucia, Via del Fosso di Fiorano 63, 00143 Rome, Italy
| | - Kirsten S. Dickson
- Div. of Neuroscience, University of Edinburgh, George Sq, Edinburgh, UK EH8 9JZ
| | - Valentina Mercaldo
- Dipartimento di Biologia, Università “Tor Vergata”, Via della Ricerca Scientifica 1. 00133 Rome, Italy
- Istituto di Neuroscienze Sperimentali, Fondazione Santa Lucia, Via del Fosso di Fiorano 63, 00143 Rome, Italy
| | - Silvia De Rubeis
- Dipartimento di Biologia, Università “Tor Vergata”, Via della Ricerca Scientifica 1. 00133 Rome, Italy
- Istituto di Neuroscienze Sperimentali, Fondazione Santa Lucia, Via del Fosso di Fiorano 63, 00143 Rome, Italy
| | - Alessandra di Penta
- Istituto di Neuroscienze Sperimentali, Fondazione Santa Lucia, Via del Fosso di Fiorano 63, 00143 Rome, Italy
| | - Elisabetta Tabolacci
- Istituto di Genetica Medica, Università Cattolica, Largo F. Vito, 1. 00168 Rome, Italy
| | - Pietro Chiurazzi
- Istituto di Genetica Medica, Università Cattolica, Largo F. Vito, 1. 00168 Rome, Italy
| | - Giovanni Neri
- Istituto di Genetica Medica, Università Cattolica, Largo F. Vito, 1. 00168 Rome, Italy
| | - Seth G.N. Grant
- Div. of Neuroscience, University of Edinburgh, George Sq, Edinburgh, UK EH8 9JZ
- Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK CB10 1SA
| | - Claudia Bagni
- Dipartimento di Biologia, Università “Tor Vergata”, Via della Ricerca Scientifica 1. 00133 Rome, Italy
- Istituto di Neuroscienze Sperimentali, Fondazione Santa Lucia, Via del Fosso di Fiorano 63, 00143 Rome, Italy
| |
Collapse
|
4120
|
Abstract
New genetic technologies are transforming nervous system studies in mice, impacting fields from neural development to the neurobiology of disease. Of necessity, alongside these methodological advances, new concepts are taking shape with respect to both vocabulary and form. Here we review aspects of both burgeoning areas. Presented are technologies which, by co-opting site-specific recombinase systems, enable select genes to be turned on or off in specific brain cells of otherwise undisturbed mouse embryos or adults. Manipulated genes can be endogenous loci or inserted transgenes encoding reporter, sensor, or effector molecules, making it now possible to assess not only gene function, but also cell function, origin, fate, connectivity, and behavioral output. From these methodological advances, a new form of molecular neuroscience is emerging that may be said to lean on the concepts of genetic access, genetic lineage, and genetic anatomy – the three ‘Gs’ – much like a general education rests on the basics of reading, ‘riting and ‘rithmetic.
Collapse
Affiliation(s)
- Susan M Dymecki
- Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
| | | |
Collapse
|
4121
|
Ernst C, Sequeira A, Klempan T, Ernst N, Ffrench-Mullen J, Turecki G. Confirmation of region-specific patterns of gene expression in the human brain. Neurogenetics 2007; 8:219-24. [PMID: 17375343 DOI: 10.1007/s10048-007-0084-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2006] [Accepted: 02/16/2007] [Indexed: 11/25/2022]
Abstract
The human brain is divided and categorized in different ways, yet a molecular genetic approach to region specificity does not exist. Using data from 12 healthy control subjects across 18 brain regions, we performed a microarray analysis using both the HG-U133AB and HG-U133 plus 2 chips for each subject to determine molecular targets showing region specificity. Using a previously published data as our guide, we confirm SIX3, GPR6, SH3RF2, and hSyn as molecular markers of the nucleus accumbens and gamma-aminobutyric-acid A receptor alpha-6, Nik-related kinase, and eomesodermin as molecular markers of the cerebellum.
Collapse
Affiliation(s)
- Carl Ernst
- McGill Group for Suicide Studies, McGill University, Montreal, QC, Canada
| | | | | | | | | | | |
Collapse
|
4122
|
Mecklenburg KL. Drosophila retinophilin contains MORN repeats and is conserved in humans. Mol Genet Genomics 2007; 277:481-9. [PMID: 17285308 DOI: 10.1007/s00438-007-0211-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2006] [Accepted: 01/13/2007] [Indexed: 11/28/2022]
Abstract
The function of conserved novel human genes can be efficiently addressed in genetic model organisms. From a collection of genes expressed in the Drosophila visual system, cDNAs expressed in vertebrates were identified and one similar to a novel human gene was chosen for further investigation. The results reported here characterize the Drosophila retinophilin gene and demonstrate that a similar gene is expressed in the human retina. The Drosophila and human retinophilin sequences are 50% identical, and they share an additional 16% conserved substitutions. Examination of the cDNA and genomic sequence indicates that it corresponds to the gene CG10233 of the annotated genome and predicts a 22.7 kDa protein. Polyclonal antibodies generated to a predicted retinophilin peptide recognize an antigen in Drosophila photoreceptor cells. The retinophilins encode 4 copies of a repeat associated with a Membrane Occupation and Recognition Nexus (MORN) function first discovered in junctophilins, which may interact with the plasma membrane. These results therefore show that Drosophila retinophilin is expressed in fly photoreceptor cells, demonstrate that a conserved human gene is expressed in human retina, and suggest that a mutational analysis of the Drosophila gene would be valuable.
Collapse
|
4123
|
|
4124
|
In Brief. Nat Rev Neurosci 2007. [DOI: 10.1038/nrn2087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
4125
|
|
4126
|
|
4127
|
|
4128
|
Abstract
The completion of the Allen Brain Atlas generated a great deal of press interest and enthusiasm from the research community. What does it do, and what other complementary resources increase its functionality?
Collapse
Affiliation(s)
- Susan E Koester
- Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health, Executive Blvd, Bethesda, MD 20892-9645, USA
| | - Thomas R Insel
- National Institute of Mental Health, Executive Blvd, Bethesda, MD 20892-9645, USA
| |
Collapse
|
4129
|
Von Stetina SE, Watson JD, Fox RM, Olszewski KL, Spencer WC, Roy PJ, Miller DM. Cell-specific microarray profiling experiments reveal a comprehensive picture of gene expression in the C. elegans nervous system. Genome Biol 2007; 8:R135. [PMID: 17612406 PMCID: PMC2323220 DOI: 10.1186/gb-2007-8-7-r135] [Citation(s) in RCA: 94] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2007] [Revised: 06/13/2007] [Accepted: 07/05/2007] [Indexed: 01/12/2023] Open
Abstract
BACKGROUND With its fully sequenced genome and simple, well-defined nervous system, the nematode Caenorhabditis elegans offers a unique opportunity to correlate gene expression with neuronal differentiation. The lineal origin, cellular morphology and synaptic connectivity of each of the 302 neurons are known. In many instances, specific behaviors can be attributed to particular neurons or circuits. Here we describe microarray-based methods that monitor gene expression in C. elegans neurons and, thereby, link comprehensive profiles of neuronal transcription to key developmental and functional properties of the nervous system. RESULTS We employed complementary microarray-based strategies to profile gene expression in the embryonic and larval nervous systems. In the MAPCeL (Microarray Profiling C. elegans cells) method, we used fluorescence activated cell sorting (FACS) to isolate GFP-tagged embryonic neurons for microarray analysis. To profile the larval nervous system, we used the mRNA-tagging technique in which an epitope-labeled mRNA binding protein (FLAG-PAB-1) was transgenically expressed in neurons for immunoprecipitation of cell-specific transcripts. These combined approaches identified approximately 2,500 mRNAs that are highly enriched in either the embryonic or larval C. elegans nervous system. These data are validated in part by the detection of gene classes (for example, transcription factors, ion channels, synaptic vesicle components) with established roles in neuronal development or function. Of particular interest are 19 conserved transcripts of unknown function that are also expressed in the mammalian brain. In addition to utilizing these profiling approaches to define stage-specific gene expression, we also applied the mRNA-tagging method to fingerprint a specific neuron type, the A-class group of cholinergic motor neurons, during early larval development. A comparison of these data to a MAPCeL profile of embryonic A-class motor neurons identified genes with common functions in both types of A-class motor neurons as well as transcripts with roles specific to each motor neuron type. CONCLUSION We describe microarray-based strategies for generating expression profiles of embryonic and larval C. elegans neurons. These methods can be applied to particular neurons at specific developmental stages and, therefore, provide an unprecedented opportunity to obtain spatially and temporally defined snapshots of gene expression in a simple model nervous system.
Collapse
Affiliation(s)
- Stephen E Von Stetina
- Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232-8240, USA
| | - Joseph D Watson
- Graduate Program in Neuroscience, Center for Molecular Neuroscience, Vanderbilt University, Nashville, TN 37232-8548, USA
| | - Rebecca M Fox
- Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232-8240, USA
- Department of Cell Biology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
| | - Kellen L Olszewski
- Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232-8240, USA
- Department of Molecular Biology, Lewis-Sigler Institute for Integrative Genomics, Princeton University 246 Carl Icahn Laboratory, Princeton NJ 08544, USA
| | - W Clay Spencer
- Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232-8240, USA
| | - Peter J Roy
- Department of Medical Genetics and Microbiology, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, M5S 1A, Canada
| | - David M Miller
- Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232-8240, USA
- Graduate Program in Neuroscience, Center for Molecular Neuroscience, Vanderbilt University, Nashville, TN 37232-8548, USA
| |
Collapse
|
4130
|
Wan X, Pavlidis P. Sharing and reusing gene expression profiling data in neuroscience. Neuroinformatics 2007; 5:161-75. [PMID: 17917127 PMCID: PMC2980754 DOI: 10.1007/s12021-007-0012-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/1999] [Revised: 11/30/1999] [Accepted: 11/30/1999] [Indexed: 12/31/2022]
Abstract
As public availability of gene expression profiling data increases, it is natural to ask how these data can be used by neuroscientists. Here we review the public availability of high-throughput expression data in neuroscience and how it has been reused, and tools that have been developed to facilitate reuse. There is increasing interest in making expression data reuse a routine part of the neuroscience tool-kit, but there are a number of challenges. Data must become more readily available in public databases; efforts to encourage investigators to make data available are important, as is education on the benefits of public data release. Once released, data must be better-annotated. Techniques and tools for data reuse are also in need of improvement. Integration of expression profiling data with neuroscience-specific resources such as anatomical atlases will further increase the value of expression data.
Collapse
Affiliation(s)
- Xiang Wan
- Department of Psychiatry and Bioinformatics Centre, University of British Columbia, Vancouver BC Canada
| | - Paul Pavlidis
- Department of Psychiatry and Bioinformatics Centre, University of British Columbia, Vancouver BC Canada
| |
Collapse
|